Company
Artica Therapeutics
Artica is leveraging covalency as key differentiator to deliver oral “ antibody-in-a-pill ” solutions for patients suffering from immune mediated conditions
Also known as ARTICA Therapeutics B.V.
- Status
- Operatingas of 2026-09-19
- Business model
- B2B
- Headquarters
- Leiden, The Netherlands
- Founded
- 2020
- Legal name
- ARTICA Therapeutics B.V.
Claim, correct or request removal
Record updated 28 September 2026
About
Artica Therapeutics is at the forefront of covalent binding technology and dedicated to developing novel and differentiated small molecule medicines for inflammatory and autoimmune indications.
Funding snapshot
- Latest round
- Seed2023-11-02
Funding rounds
- Seed
- 2023-11-02
Loading relationship preview